Bastian PJ - Search Results

1

CpG island hypermethylation profile in the serum of men with clinically localized and hormone refractory metastatic prostate cancer.

Bastian PJ, Palapattu GS, Yegnasubramanian S, Rogers CG, Lin X, Mangold LA, Trock B, Eisenberger MA, Partin AW, Nelson WG. Bastian PJ, et al. J Urol. 2008 Feb;179(2):529-34; discussion 534-5. doi: 10.1016/j.juro.2007.09.038. J Urol. 2008. PMID: 18076941 Free PMC article.

2

[GSTP1 CpG island hypermethylation as a molecular marker of prostate cancer].

Bastian PJ, Nakayama M, De Marzo AM, Nelson WG. Bastian PJ, et al. Urologe A. 2004 May;43(5):573-9. doi: 10.1007/s00120-004-0540-7. Urologe A. 2004. PMID: 15029477 Review. German.

3

Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.

Bastian PJ, Palapattu GS, Yegnasubramanian S, Lin X, Rogers CG, Mangold LA, Trock B, Eisenberger M, Partin AW, Nelson WG. Bastian PJ, et al. Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5361-7. doi: 10.1158/1078-0432.CCR-06-2781. Clin Cancer Res. 2007. PMID: 17875764

4

Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection.

Nielsen ME, Bastian PJ, Palapattu GS, Trock BJ, Schoenberg MP, Chan T, Rogers CG. Nielsen ME, et al. Among authors: bastian pj. Urology. 2007 Dec;70(6):1091-5. doi: 10.1016/j.urology.2007.08.044. Urology. 2007. PMID: 18158024

5

Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysis.

Bastian PJ, Mangold LA, Epstein JI, Partin AW. Bastian PJ, et al. Cancer. 2004 Nov 1;101(9):2001-5. doi: 10.1002/cncr.20586. Cancer. 2004. PMID: 15372478 Free article.

6

Molecular biomarker in prostate cancer: the role of CpG island hypermethylation.

Bastian PJ, Yegnasubramanian S, Palapattu GS, Rogers CG, Lin X, De Marzo AM, Nelson WG. Bastian PJ, et al. Eur Urol. 2004 Dec;46(6):698-708. doi: 10.1016/j.eururo.2004.07.022. Eur Urol. 2004. PMID: 15548435 Review.

7

Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.

Bastian PJ, Palapattu GS, Lin X, Yegnasubramanian S, Mangold LA, Trock B, Eisenberger MA, Partin AW, Nelson WG. Bastian PJ, et al. Clin Cancer Res. 2005 Jun 1;11(11):4037-43. doi: 10.1158/1078-0432.CCR-04-2446. Clin Cancer Res. 2005. PMID: 15930338

8

Relationship between primary Gleason pattern on needle biopsy and clinicopathologic outcomes among men with Gleason score 7 adenocarcinoma of the prostate.

Gonzalgo ML, Bastian PJ, Mangold LA, Trock BJ, Epstein JI, Walsh PC, Partin AW. Gonzalgo ML, et al. Among authors: bastian pj. Urology. 2006 Jan;67(1):115-9. doi: 10.1016/j.urology.2005.07.037. Urology. 2006. PMID: 16413345

9

Cancer specific outcomes in patients with pT0 disease following radical cystectomy.

Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Lotan Y, Vazina A, Gupta A, Sagalowsky AI, Lerner SP, Schoenberg MP; Bladder Cancer Research Consortium. Palapattu GS, et al. Among authors: bastian pj. J Urol. 2006 May;175(5):1645-9; discussion 1649. doi: 10.1016/S0022-5347(05)00995-X. J Urol. 2006. PMID: 16600721

10

Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.

Rogers CG, Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Lotan Y, Gupta A, Vazina A, Gilad A, Sagalowsky AI, Lerner SP, Schoenberg MP. Rogers CG, et al. Among authors: bastian pj. J Urol. 2006 Jun;175(6):2048-53; discussion 2053. doi: 10.1016/S0022-5347(06)00317-X. J Urol. 2006. PMID: 16697800

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

226 results

Search Page